GO
Loading...

Cramer's stocks to watch: Intercept & Exact Sciences

Tuesday, 12 Aug 2014 | 8:49 AM ET

CNBC's Jim Cramer explains why he thinks Intercept's liver drug is going to be big news, and shares his thoughts on the FDA's approval of Exact Sciences' DNA test for colon cancer.